发明人赵玉洁,韩伟,王建平. "Method for the Synthesis of Rivastigmine Hydrogen Tartrate EP Impurity E HCl" [P]. 中国发明专利, 专利号 CN 113351073 A, 授权公告日 2022-08-20.
发明人郑宇鹏,杨光,林芳. "A Process for Preparing High-Purity Rivastigmine Hydrogen Tartrate EP Impurity E HCl" [P]. 中国发明专利, 专利号 CN 113057426 B, 授权公告日 2021-06-18.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 卡巴拉汀EP杂质E HCl in Pharmaceutical Formulations". Anal. Methods, 2010, 1054, (2), 1962-1985.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 卡巴拉汀EP杂质E HCl as an Impurity". Biomed. Chromatogr., 2010, 508, 4860-4871.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Rivastigmine Hydrogen Tartrate EP Impurity E HCl Using HRMS and NMR". Sci. Total Environ., 2023, 1137, (1), 8046-8071.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 卡巴拉汀EP杂质E HCl Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2021, 1280, (1), 5176-5199.